Ken Song

Company: Rayze BIO

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Review of the Last 12 Months of Development of Alpha Emitting Therapies 5:00 pm

Discuss how Lutathera has changed the game for RLT developers and what it has taught us about RLT’s place on the wider oncology field Explore what key learnings have been uncovered by VISION trial and other recent analyses of alphaemitters’ clinical applicationsRead more

day: Day Two